Law360, Washington (May 04, 2012, 9:27 PM ET) -- U.S. antitrust officials vowed Thursday and Friday to watch accountable care organizations closely to make sure they actually provide the savings and improved quality promised, but emphasized that the benefits of the new health care collaborations remained unproven.
Officials from the U.S. Department of Justice and the Federal Trade Commission promised to closely examine data that ACOs participating in Medicare must submit to the federal government. ACOs — one of the health care reform law’s centerpieces — are designed to encourage providers to coordinate patient care...
Antitrust Officials Still Skeptical On ACO Benefits
To view the full article, take a free trial now.
